Clinical Trials Browser

Phase 2 × Recruiting × raltitrexed × Clear all

NCT07327788 2026-01-13

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Phase 2 Recruiting

Hepatecellular Carcinoma

NCT06427005 2025-01-22

Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC

Phase 2 Recruiting

Fruquintinib

NCT05628038 2024-10-01

TORCH-R

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms